| Product Code: ETC8262573 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of neuraminidase inhibitors to Mauritius in 2024 saw a shift in market concentration levels, transitioning from high concentration in 2023 to moderate concentration. Key exporting countries to Mauritius included India, Metropolitan France, Germany, Turkey, and the UK. The compound annual growth rate (CAGR) for the period 2020-2024 was a healthy 4.71%, indicating steady growth in the market. However, there was a slight decline in growth rate from 2023 to 2024 at -1.38%, suggesting a possible stabilization phase in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Neuraminidase Inhibitors Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Neuraminidase Inhibitors Market - Industry Life Cycle |
3.4 Mauritius Neuraminidase Inhibitors Market - Porter's Five Forces |
3.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mauritius Neuraminidase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Neuraminidase Inhibitors Market Trends |
6 Mauritius Neuraminidase Inhibitors Market, By Types |
6.1 Mauritius Neuraminidase Inhibitors Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2021- 2031F |
6.1.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2021- 2031F |
6.1.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mauritius Neuraminidase Inhibitors Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2021- 2031F |
6.2.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2021- 2031F |
6.2.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2021- 2031F |
6.2.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2021- 2031F |
6.2.6 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Mauritius Neuraminidase Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2021- 2031F |
6.3.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mauritius Neuraminidase Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mauritius Neuraminidase Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Mauritius Neuraminidase Inhibitors Market Import-Export Trade Statistics |
7.1 Mauritius Neuraminidase Inhibitors Market Export to Major Countries |
7.2 Mauritius Neuraminidase Inhibitors Market Imports from Major Countries |
8 Mauritius Neuraminidase Inhibitors Market Key Performance Indicators |
9 Mauritius Neuraminidase Inhibitors Market - Opportunity Assessment |
9.1 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mauritius Neuraminidase Inhibitors Market - Competitive Landscape |
10.1 Mauritius Neuraminidase Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |